Increased expression of Fas ligand on Mycobacterium tuberculosis infected macrophages: A potential novel mechanism of immune evasion by Mycobacterium tuberculosis?

Inflammation

Volumn 23, Issue 6, 1999, Pages 507-521

  Mustafa, Tehmina ^a   Phyu, Sabai ^a   Nilsen, Rune ^a   Bjune, Gunnar ^a,b   Jonsson, Roland ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CHRONIC GRANULOMATOUS DISEASE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LEUKOCYTE AGGREGATION; MACROPHAGE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTEIN EXPRESSION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; FAS LIGAND PROTEIN; FEMALE; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 0032708632     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. LURIE, M. B. 1964. Resistance to Tuberculosis. Experimental studies in native and acquired defensive mechanisms. Harvard University Press. Cambridge, Mass.
2. DANNENBERG, A. M. Jr., and G. A. W. ROOK. 1994. Pathogenesis of pulmonary tuberculosis: an interplay of tissue-damaging and macrophage-activating immune responses-dual mechanisms that control bacillary multiplication. In: Bloom, B. R. (editor). Tuberculosis; pathogenesis, protection, and control. Washington DC. pp. 459.
3. GOMEZ, J., B. POHAJDAK, S. O'NEILL, J. WILKINS, and A. H. GREENBERG. 1985. Activation of rat and human alveolar macrophages intracellular microbicidal activity by a preformed LGL cytokine. J. Immunol. 135:1194.
4. NORTH, R. J. 1974. Cell mediated Immunity and the response to infection. In: McCluskey, R. T. and S. Cohen (editors), Mechanisms of cell-mediated immunity. John Wiley & Sons, Inc. pp. 185.
5. MACKANESS, G. H. 1968. The immunology of antituberculous immunity. Am. Rev. Respir. Dis. 97:337.
6. ORME, I. M., and P. ANDERSON, 1993. T-Cell response to Mycobacterium Tuberculosis. J. Infect. Dis. 167:1481.
7. KALE, Ab. B., R. KIESSLING, J. D. VAN-EMBDEN, J. E. THOLE, D. S. KUMARARATNE, P. PISA, A. WONDIMU, and T. H. OTTENHOFF. 1990. Induction of antigen-specific CD4+HLA-DR-restricted cytotoxic T lymphocytes as well as nonspecific nonrestricted killer cells by the recombinant mycobacterial 65-kDa heat-shock protein. Eur. J. Immunol. 20:369.
8. TSUKAGUCHI, K., and K. N. BALAJI. 1995. CD4+ alpha beta T cell and gamma delta T cell responses to Mycobacterium tuberculosis. Similarities and differences in Ag recognition, cytotoxic effector function, and cytokine production. J Immunol. 154:1786.
9. MOHAGHEGHPOUR, N., D. GAMMON, L. M. KAWAMURA, A. VAN VOLLENHOVEN, C. J. BENIKE, and K. G. ENGLEMAN. 1998. CTL response to Mycobacterium tuberculosis: identification of an immunogenic epitope in the 19-kDa lipoprotein. J. Immunol. 161:2400.
10. KAGI, D., F. VIGNAUX, B. LEDERMANN, K. BURKI, V. DEPRAETERE, S. NAGATA, H. HENGARTNER, and P. GOLDSTEIN. 1994. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528.
11. UCKER, D. S., J. D. WILSON, and L. D. HEBSHI. 1994. Target cell death triggered by cytotoxic T lymphocytes: a target cell mutant distinguishes passive pore formation and active cell suicide mechanisms. Mol. Cell. Biol. 14:427.
12. HENKART, P. 1985. A. Mechanisms of lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol. 3:31.
13. TRAUTH, B. C., C. KLAS, A. M. J. PETERS, S. MATZKU, P. MOLLER, W. FALK, K. M. DEBATIN, and P. H. KRAMMER. 1989. Monoclonal antibody-mediated tumour regression by induction of apoptosis. Science 245:301.
14. VIGNAUX, F., E. VIVIER, B. MALISSEN, V. DEPRAETERE, S. NAGATA, and P. GOLDSTEIN. 1995. TCR/CD3 coupling to Fas-based cytotoxicity. J. Exp. Med. 181:781.
15. SUDA, T., T. TAKAHASHI, P. GOLDSTEIN, and S. NAGATA. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumour necrosis factor family. Cell 75:1169.
16. ODDO. M., T. RENNO, A. ATTINGER, T. BAKKER, H. R. MACDONALD, and P. R. MEYLAN. 1998. Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J. Immunol. 160:5448
17. OTTENHOFF, T. H., and T. MUTIS. 1995. Role of cytotoxic cells in the protective immunity against and immunopathology of intracellular infections. Eur. J. Clin. Invest. 25:371.
18. CHAN, J., and S. H. E. KAUFMANN. 1994. Immune mechanisms of protection. In: Bloom, B. R. (editor). Tuberculosis; pathogenesis, protection, and control. Washington, DC. pp. 389.
19. DURRBAUM-LANDMANN, J. GERCKEN, H. D. FLAD, and M. ERNST. 1996. Effect of in vitro infection of human monocytes with low numbers of Mycobacterium tuberculosis bacteria on monocyte apoptosis. Infect. Immun. 64:5384.
20. KEANE, J., M. K. BALCEWICZ-SABLINSKA, H. G. REMOLD, G. L. CHUPP, B. B. MEEK, M. J. FENTON, and H. KORNFELD. 1997. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect. Immun. 65:298.
21. BALCEWICZ-SABLINSKA, M. K., J. KEANE, H. KORNFELD, and H. G. REMOLD. 1998. Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-α. J. Immunol. 161:2636.
22. ROJAS, M., L. F. BARRERA, G. PUZO, and L. F. GARCIA. 1997. Differential induction of apoptosis by virulent Mycobacterium tuberculosis in resistant and susceptible murine macrophages. Role of nitric oxide and mycobacterial products. J. Immunol. 159:1352.
23. KREMMER, L., J. ESTAQUIER, E. BRANDT, J-C. AMEISEN, and C. LOCHT. 1997. Mycobacterium bovis Bacillus Calmette Guerin infection prevents apoptosis of resting human monocytes. Eur. J. Immunol. 27:2450.
24. MUSTAFA, T., S. PHYU, R. NILSEN, R. JONSSON, and G. BJUNE. 1999. A mouse model for slowly progressive primary tuberculosis. Scand. J. Immunol. 50:127.
25. RHOADES, E. R., A. A. FRANK, and I. M. ORME. 1997. Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. Tuberc. Lung Dis. 78:57.
26. PHYU, S., T. MUSTAFA, T. HOFSTAD, R. NILSEN, R. FOSSE, and G. BJUNE. 1998. A mouse model for latent tuberculosis. Scand. J. Infect. Dis. 30:59.
27. CLOSS, O., M. HARBOE, N. H. AXELSEN, K. BUNCH-CHRISTENSEN, and M. MAGNUSSEN. 1980. The antigens or Mycobacterium bovis, strain BCG, studied by crossed immunoelectrophoresis: A reference system. Scand. J. Immunol. 12:246.
28. WILEY, E. L., T. J. MULHOLLAN, B. BECK, J. A. TYNDALL, and R. G. FREEMANN. 1990. Polyclonal antibodies raised against Bacillus Calmette-Guerin, Mycobacterium duvalii and Mycobacterium paratuberculosis used to detect mycobacteria in tissues with the use of immunohistochemical techniques. Am. J. Clin. Path. 94:307.
29. GAVRIELI, Y., Y. SHERMAN, and S. A. BEN-SASSON. 1992. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J. Cell Biol. 119:493.
30. SURH, C. D., and J. SPRENT. 1994. T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 372:100.
31. BURSCH, W. 1990. The biochemistry of cell death by apoptosis. Biochem. Cell Biol. 68:1071.
32. MOORE, K. J., and G. MATLASHEWSKI. 1994. Intracellular infection by Leishmania donovani inhibits macrophage apoptosis. J. Immunol. 152:2930.
33. THOMPSON, C. B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456.
34. MANGAN, D. F., G. R. WELCH, and S. M. WAHL. 1991. Lipopolysaccharide, tumour necrosis factor-α, and IL-1β prevent programmed cell death (apoptosis) in human peripheral blood monocytes. J. Immunol. 146:1541.
35. MANGAN, D. F., and S. M. WAHL. 1991. Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and proinflammatory cytokines. J. Immunol. 147:3408.
36. HENSON, P. M., and D. W. RICHES. 1994. Modulation of macrophage maturation by cytokines and lipid mediators: a potential role in resolution of pulmonary inflammation. Ann. N.Y. Acad. Sci. 725:298.
37. BADLEY, A. D., J. A. McELHINNY, P. J. LEIBSON, D. H. LYNCH, M. R. ALDERSON, and C. V. PAYA. 1996. Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J. Virol. 70:199.
38. BONFOCO, E., P. M. STUART, T. BRUNNER, T. LIN, T. S. GRIFFITH, Y. GAO, H. NAKAJIMA, P. A. HENKART, T. A. FERGUSON, and D. R. GREEN. 1998. Inducible Nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells. Immunity 9:711.
39. STRAND, S., W. J. HOFMANN, H. HUG, M. MULLER, G. OTTO, D. STRAND, S. M. MARIANI, W. STREMMEL, P. H. KRAMMER, and P. R. GALLE. 1996. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumour cells-A mechanism of immune evasion? Nature Med. 2:1361.
40. HAHNE, M., D. RIMOLDI, M. SCHROTER, P. ROMERO, M. SCHREIER, L. E. FRENCH, P. SCHNEIDER, T. BORNAND, A. FONTANA, D. LIENARD, J. CEROTTINI, and J. TSCHOPP. 1996. Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape. Science 274:1363.
41. NIEHANS, G. A., T. BRUNNER, S. P. FRIZELLE, J. C. LISTON, C. T. SALERNO, D. J. KNAPP, D. R. GREEN, and K. A. KRATZKE. 1997. Human lung carcinomas express Fas ligand. Cancer Res., 57:1007.
42. SUDA, T., T. TAKAHASHI, P. GOLSTEIN, and S. NAGATA. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumour necrosis factor family. Cell 75:1169.
43. BELLGRAU, D., D. GOLD, S. HELENA, J. MOORE, A. FRANZUSOFF, and R. C. DUKE. 1995. A role for CD95 ligand in preventing graft rejection. Nature 377:630.
44. GRIFFITH, T. S., T. BRUNNER, S. M. FLETCHER, D. R. GREEN, and T. A. FERGUSON. 1995. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270:1189.
45. SAAS, P., P. R. WALKER, M. HAHNE, A. L. QUIQUEREZ, V. SCHNURIGER, G. PERRIN, L. FRENCH, E. G. VANMEIR, N. DE-TRIBOLET, J. TSCHOPP, and P. Y. DIETRICH. 1997. Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? J. Clin. Invest. 99:1173.